医疗领域智能体 AI 治理平台市场（2026—2031）
医疗领域智能体 AI 治理平台市场规模预计由2026年的84.8亿美元增至2031年的139.3亿美元，预测期复合年增长率为10.44%。北美是当前最大市场，亚太地区增长最快。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
医疗领域智能体 AI 治理平台市场规模预计由2026年的84.8亿美元增至2031年的139.3亿美元，预测期复合年增长率为10.44%。北美是当前最大市场，亚太地区增长最快。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 10.44% | 机构预测 |
| 市场规模 | 2026 | USD 8.48 billion | 机构预测 |
| 市场规模 | 2031 | USD 13.93 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| deployment_model | cloud-based platforms | 2025 | 54.120% |
| end_user | healthcare providers | 2025 | 38.470% |
| function | runtime guardrails and human oversight | 2025 | 24.160% |
| geography | North America | 2025 | 42.810% |
| offering | software | 2025 | 68.230% |
| organization_size | large organizations | 2025 | 71.380% |
关键结论
- deployment_model 维度中，cloud-based platforms 在 2025 年的公开份额为 54.12%。
- end_user 维度中，healthcare providers 在 2025 年的公开份额为 38.47%。
- function 维度中，runtime guardrails and human oversight 在 2025 年的公开份额为 24.16%。
- geography 维度中，North America 在 2025 年的公开份额为 42.81%。
- offering 维度中，software 在 2025 年的公开份额为 68.23%。
- organization_size 维度中，large organizations 在 2025 年的公开份额为 71.38%。
主要参与者
- Microsoft Corporation
- International Business Machines Corporation
- Google LLC
- SAS Institute Inc.
- Credo AI Corporation
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Rising Healthcare AI Deployment and Accountability Requirements | +2.800% | Global, concentrated demand in the United States, United Kingdom, and European Union | Short term (≤ 2 years) |
| Expansion of Agentic Workflows Across Clinical and Administrative Care | +2.100% | North America and European Union, with spillover to Asia-Pacific | Medium term (2-4 years) |
| Increasing Regulatory Requirements for Lifecycle Evidence | +1.700% | European Union core, with adoption in the United States, Canada, Australia, and Singapore | Medium term (2-4 years) |
| Growth of Cloud-Based AI Governance Infrastructure | +1.200% | Global, with early gains in North America and North Asia | Short term (≤ 2 years) |
| Pre-Execution Policy Enforcement for Autonomous Healthcare Agents | +0.800% | North America and European Union, with spillover to Asia-Pacific | Medium term (2-4 years) |
| Synthetic-Population Testing for Rare and Vulnerable Patient Scenarios | +0.400% | North America, European Union, and selected Asia-Pacific countries | Long term (≥ 4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Fragmented Cross-Border Health-Data and AI Regulation | -1.300% | Global, most acute in European Union-U.S. and Asia-Pacific cross-border deployments | Medium term (2-4 years) |
| Shortage of Clinical AI Risk and Validation Specialists | -0.900% | Global, most severe in Asia-Pacific and South America | Short term (≤ 2 years) |
| Hidden Governance Cost of Legacy EHR Integration | -0.600% | North America and Europe, given Epic and Cerner dominance | Medium term (2-4 years) |
| Liability Ambiguity for Autonomous Agent Decisions | -0.400% | Global, most acute in U.S. and European Union medical liability systems | Long term (≥ 4 years) |
报告关注的关键问题
What is the size of the Agentic AI Governance Platforms in Healthcare Market?
The Agentic AI Governance Platforms in Healthcare Market is expected to increase from USD 5.51 billion in 2025 to USD 8.48 billion in 2026 and reach USD 13.93 billion by 2031, at a 10.44% CAGR.
Which offering holds the largest share?
Software held 68.23% share in 2025 because healthcare buyers need repeatable policy enforcement, audit records, and agent controls.
Which deployment model is growing fastest?
Hybrid deployment is projected to grow at 11.82% CAGR through 2031, supported by organizations that need both local data control and cloud-based governance services.
Which function leads healthcare AI governance adoption?
Runtime guardrails and human oversight held 24.16% share in 2025 because buyers need real-time checks before agents take actions.
Which end user is growing fastest?
Pharmaceutical and biotechnology firms are forecast to grow at 12.26% CAGR through 2031 as they use agents across drug discovery and clinical research workflows.
Which region is projected to grow fastest?
Asia-Pacific is forecast to expand at 12.37% CAGR through 2031 as regulatory frameworks for healthcare AI mature across China, Japan, and Singapore.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence